Clozapine drug-drug interactions: A review of the literature

Human Psychopharmacology

Volumn 12, Issue 1, 1997, Pages 5-20

  Edge, Stacy C ^a   Markowitz, John S ^a   Devane, C Lindsay ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

clozapine; drug interaction; polypharmacy

Indexed keywords

AMPICILLIN; CAFFEINE; CARBAMAZEPINE; CIMETIDINE; CLOBAZAM; CLOZAPINE; DIAZEPAM; ENALAPRIL; ERYTHROMYCIN; FLUOXETINE; FLUVOXAMINE; LORAZEPAM; LORMETAZEPAM; MECLOZINE; METHAZOLAMIDE; NORTRIPTYLINE; PAROXETINE; PHENYTOIN; PROPRANOLOL; RISPERIDONE; SERTRALINE; VALPROIC ACID;

ADVERSE DRUG REACTION; DRUG INTERACTION; DRUG POTENTIATION; HUMAN; MEDICAL LITERATURE; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL; REVIEW;

EID: 0031038936     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199701/02)12:1<5::AID-HUP831>3.0.CO;2-4     Document Type: Review

References (79)

1. Alvir, J. M., Lieberman, J. A., Safferman, A. Z., Schwimmer, J. L. and Schaff, J. A. (1993). Clozapine-induced agranulocytosis, incidence and risk factors in the United States. New England Journal of Medicine, 329, 162-167.
2. Aronowitz, J., Chakos, M. J. and Safferman, A. (1994). Syncope associated with the combination of clozapine and enalapril. Journal of Clinical Psychopharmacology, 14, 429-430.
3. Baldessarini, R. J. and Frankenburg, F. R. (1991). Clozapine a novel antipsychotic agent. New England Journal of Medicine, 324, 746-754.
4. Blake, L. M., Marks, R. C. and Luchins, D. J. (1992). Reversible neurologic symptoms with clozapine and lithium. Journal of Clinical Psychopharmacology, 12, 297-298.
5. Bondesson, V. and Lindstrom, L. H. (1988). Determination of clozapine and its N-demethylated metabolite in plasma by use of gas chromatography-mass spectrometry with single ion detection. Psychopharmacology, 95, 472-475.
6. Briant, R. H. and Diamond, B. I. (1973). Interaction between clonidine and desipramine in man. British Medical Journal, 852, 522-523.
7. Burke, W. J. and Ranno, A. E. (1994). Neutropenia with clozapine and methazolamide. Journal of Clinical Psychopharmacology, 14, 357-358.
8. Carrillo, J. A., Jerling, M. and Bertilsson, L. (1995). Comments to 'Interaction between caffeine and clozapine'. Journal of Clinical Psychopharmacology, 15, 376-377.
9. Centorrino, F., Baldissarini, R. J., Kando, J., Frankenburg, F. R., Volpicelli, S. A., Puopolo, P. R. and Flood, J. G. (1994). Serum concentration of clozapine and its major metabolite effects of cotherapy with fluoxetine or valproate. American Journal of Psychiatry, 151, 123-125.
10. Centorrino, F., Baldessarini, R. J., Frankenburg, F. R., Kando, J., Volpicelli, S. A., and Flood, J. G. (1996). Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors. American Journal of Psychiatry, 153, 820-822.
11. Cobb, C., Anderson, C. and Seidel, D. (1991). Possible interaction between clozapine and lorazepam. American Journal of Psychiatry, 148, 1606-1607.
12. Cohen, L. G., Chesley, S., Eugenio, L., Flood, J. G., Fisch, J. and Goff, D. C. (1996). Erythromycin-induced clozapine toxic reaction. Archives of Internal Medicine, 156, 675-677.
13. Cohen, M. (1994). Development of urinary retention during treatment with clozapine and meclizine. American Journal of Psychiatry, 151, 952.
14. Costello, L. and Suppes, T. (1995). A clinically significant interaction between clozapine and valproate. Journal of Clinical Psychopharmacology, 15, 139-140.
15. Crewe, H. K., Lennard, M. S., Tucker, G. T., Woods, F. R. and Haddock, R. E. (1992). The effect of selective serotonin reuptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. British Journal of Clinical Pharmacology, 45, 1211-1214.
16. Csik, V., Molner, J. (1994). Possible adverse interaction between clozapine and ampicillin in an adolescent with schizophrenia. Journal of Child and Adolescent Psychopharmacology, 4, 123-127.
17. Dahl, M-L., Llerena, A., Bondesson, U., Lindstrom, L. and Bertilsson, L. (1994). Disposition of clozapine in man: lack of association with debrisoquine and S-mephenytoin hydroxylation polymorphisms. British Journal of Clinical Pharmacology, 37, 71-74.
18. Dequardo, J. R. and Roberts, M. (1996). Elevated clozapine levels after fluvoxamine initiation. American Journal of Psychiatry, 153, 840-841.
19. DeVane, C. L. (1996). Drug interactions and anti-psychotic therapy. Pharmacotherapy, 16, 15S-20S.
20. Dumortier, G., Lochu, A., De Melo, P. C., Ghribi, O., Rabreau, D. R., Degrassat, K. and Desce, J. M. (1996). Elevated clozapine plasma concentrations after fluvoxamine initiation. American Journal of Psychiatry, 153, 738-739.
21. Eggert, A. C., Crismon, M. L. and Dovjon, P. G. (1994). Lack of effect of fluxoetine on plasma clozapine concentration. Journal of Clinical Psychiatry, 55, 454-455.
22. Ereshefsky, L., Watanabe, M. D. and Tran-Johnson, T. (1989). Clozapine: an atypical antipsychotic agent. Clinical Pharmacy, 8, 691-709.
23. Fann, W. E., Davis, J. M., Janowsky, D. S., Sekerke, H. J. and Schmidt, D. M. (1974). Chlorpromazine effect of antacids on its gastrointestinal absorption. Journal of Clinical Psychopharmacology, 13, 229.
24. Finley, P. and Warner, D. (1994). Potential impact of valproic acid therapy on clozapine disposition. Biological Psychiatry, 36, 487-488.
25. Fisher, V., Vogels, B., Mauer, G. and Tynes, R. (1992). The antipsychotic clozapine is metabolized by the polymorphic human microsomal and recombinant cytochrome P450 2D6. Journal Pharmacology and Experimental Therapeutics, 260, 1355-1360.
26. Funderburg, L., Vertrees, J., True, J. and Miller, A. (1994). Seizure following addition of erythromycin to clozapine therapy. American Journal of Psychiatry, 151, 1840-1841.
27. Garcia, G., Crismon, M. L. and Dorson, P. G. (1994). Seizures in two patients after the addition of lithium to a clozapine regimen. Journal of Clinical Psychopharmacology, 14, 426-427.
28. Gauch, R. and Michaelis, W. (1971). The metabolism of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4] diazepine (clozapine) in mice, dogs, human subjects. Farmaco, 26, 667-681.
29. Gerson, S. L., Arce, C. and Meltzer, H. Y. (1994). N-desmethylclozapine: a clozapine metabolite that suppresses haemopoiesis. British Journal of Haematology, 86, 555-561.
30. Gillan, J. G., Israel, D. S. and Polk, R. E. (1993). Pharmacokinetic drug interactions with antimicrobial agents. Clinical Pharmacokinetics, 25, 450-482.
31. Godleski, L. S. and Sernyak, M. J. (1996). Agranulocytosis after addition of risperidone to clozapine treatment. American Journal of Psychiatry, 153, 735-736.
32. Greendyke, R. M. and Kanter, D. R. (1987). Plasma propranolol levels and their effects on plasma thioridazine and haloperidol concentrations. Journal of Clinical Psychopharmacology, 7, 178-182.
33. Grohman, R., Ruther, E., Sassim, N. and Schmidt, L. G. (1989). Adverse effects of clozapine. Psychopharmacology, 99, 101S-104S.
34. Haring, C., Fleischhacker, W., Schett, P. and Humpel, C. (1990). Influence of plasma related variables on clozapine levels. American Journal of Psychiatry, 147, 1471-1475.
35. Haring, C., Meise, U., Humpel, C., Saria, A., Fleischhacker, W. W. and Hinterhuber, H. (1989). Dose-related plasma level of clozapine: influence of smoking behavior, sex, and age. Psychopharmacology, 99, 538-540.
36. Hasegawa, M., Guiterrez, R., Way, L. and Meltzer, H. Y. (1993). Relationship between clinical efficacy and clozapine concentration in plasma in schizophrenia: effect on smoking. Journal of Clinical Psychopharmacology, 13, 383-390.
37. Hellwig, B., Heblinger, B. and Waiden, J. (1996). Acute brain syndrome after tapering off clozapine in clozapine-lithium combination. Progress in Neuropsychopharmacology & Biological Psychiatry, 20, 179-183.
38. Hiemke, C., Weigmann, H., Hartter, S., Dahmen, N., Wetzel, H. and Muller, H. (1994). Elevated level of clozapine in serum after addition of fluvoxamine. Journal of Clinical Psychopharmacology, 14, 279-281.
39. Jackson, C. W., Markowitz, J. S. and Brewerton, T. D. (1995). Delirium associated with clozapine and benzodiazepine combinations. Annals of Clinical Psychiatry, 7, 139-141.
40. Jann, M. W., Ereshefsky, L., Saklad, S. R., Seidel, D. R., Davis, C. M., Burch, N. R. and Bowden, C. L. (1985). Effects of carbamazepine on plasma haloperidol. Journal of Clinical Psychopharmacology, 5, 106-109.
41. Jann, M. W., Lam, Y. W. and Chang, W. H. (1994). Rapid formation of clozapine in guinea-pigs and man following clozapine-N-oxide administration. Archives of International Pharmacodynamics and Therapeutics, 328, 243-250.
42. Jerling, M., Lindstrom, L., Bondesson, U. and Bertilsson, L. (1994). Fluvoxamine inhibition and carbamazepine induction of the metabolism of clozapine: evidence from a therapeutic drug monitoring service. Therapeutic Drug Monitoring, 16, 368-374.
43. Junghan, U., Albers, M. and Woggon, B. (1993). Increased risk of hematological side-effect in psychiatric patients treated with clozapine and carbamazepine? Pharmacopsychiatry, 26, 262.
44. Kane, J., Honigfeld, G., Singer, J. and Meltzer, H. Y. (1988). Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 786-789.
45. Klimke, A. and Klieser, E. (1994). Sudden death after intravenous application of lorazepam in a patient treated with clozapine. American Journal of Psychiatry, 151, 780.
46. Koreen, A. R., Lieberman, J. A., Kronig, M. and Cooper, T. B. (1995). Cross-tapering clozapine and risperidone. American Journal of Psychiatry, 152, 1690.
47. Kuoppamaki, M., Syvalahti, E. and Hietala, J. (1993). Clozapine and N-desmethylclozapine are potent 5-HT1c receptor antagonists. European Journal of Pharmacology, 245, 179-182.
48. Lieberman, J. A. and Safferman, A. Z. (1992). Clinical profile of clozapine: adverse reactions and agranulocytosis. Psychiatric Quarterly, 63, 51-70.
49. Luo, H., McKay, G. and Midha, K. K. (1994). Identification of clozapine N-glucuronide in the urine of patients treated with clozapine using electrospray mass spectrometry. Biological Mass Spectrometry, 23, 147-148.
50. Markowitz, J. S. and Patrick, K. S. (1993). Evidence of clozapine glucuronide in patient urine using GC-MS. Journal of Clinical Pharmacology, 33, 1000.
51. Markowitz, J. S., Wells, B. G. and Carson, W. H. (1995). Interactions between antipsychotic and anti-hypertensive drugs. Annals of Pharmacotherapy, 29, 603-609.
52. McCarthy, R. (1994). Seizure following smoking cessation in a clozapine responder. Pharmacopsychiatry, 27, 210-211.
53. McElroy, S. L., Dessain, E. C., Pope, H. G., Cole, J. O., Keck, P. E., Frankenburg, F. R., Aizley, H. G. and O'Brien, S. (1991). CLozapine in the treatment of psychiatric mood disorder, schizoaffective disorder and schizophrenia. Journal of Clinical Psychiatry, 52, 411-414.
54. Miller, D. (1991). Effect of phenytoin on plasma clozapine concentration in two patients. Journal of Clinical Psychiatry, 52, 23-25.
55. Muller, T., Becker, T. and Frietze, J. (1988). Neuroleptic malignant syndrome after clozapine plus carbamazepine. Lancet, 2, 1500.
56. Odum-White, A. and de Leon, J. (1996). Clozapine levels and caffeine. Journal of Clinical Psychiatry, 57, 175-176.
57. Peet, M., Middlemiss, D. N. and Yates, R. A. (1980). Pharmacokinetic interaction between propranolol and chlorpromazine in schizophrenic patients. Lancet, ii, 978.
58. Peterson, G. A. and Byrd, S. L. (1996). Diabetic ketoacidosis from clozapine and lithium cotreatment. American Journal of Psychiatry, 153, 737-738.
59. Pirmohamed, M., Williams, D., Madden, S., Templeton, E. and Park, B. K. (1995). Metabolism and bioactivation of clozapine by human liver in vitro. Journal of Pharmacology and Experimental Therapeutics, 272, 984-990.
60. Pollock, B. G. (1994). Recent developments in drug metabolism relevant to psychiatrists. Harvard Reviews in Psychiatry, 2, 204-213.
61. Pope, H. G., Cole, J. O., Choras, P. T. and Fulwiler, C. E. (1986). Apparent neuroleptic malignant syndrome with clozapine and lithium. Journal of Nervous and Mental Disease, 174, 493-495.
62. Raitasuo, V., Lehtovaara, R. and Huttuner, M. (1993). Carbamazepine and plasma levels of clozapine. American Journal of Psychiatry, 150, 169.
63. Rolan, P. E. (1994). Plasma protein binding displacement reactions - why are they still regarded as clinically important? British Journal of Clinical Pharmacology, 37, 125-128.
64. Sassim, N. and Grohman, R. (1988). Adverse drug reaction with clozapine and simultaneous application of benzodiazipines. Pharmacopsychiatry, 21, 306-307.
65. Shroder, S. and Calabrese, P. (1995). Clozapine plasma levels. Pharmacopsychiatry, 28, 214.
66. Siris, S. G. (1993). Adjunctive medication in the maintenance treatment of schizophrenia and its conceptual implications. British Journal of Psychiatry, 163, 66-78.
67. Smith, T. and Risken, J. (1994). Effect of clozapine on plasma nortriptyline concentration. Pharmacopsychiatry, 27, 41-42.
68. Spatzenegger, M. and Jaeger, W. (1995). Clinical importance of hepatic cytochrome P450 in drug metabolism. Drug Metabolism Reviews, 27, 397-417.
69. 3-bei der metabolisierung des clozapins im menschlichen korper. Arzneimittelforschung, 27, 982-990.
70. Szegedi, A., Weisner, J. and Hiemke, C. (1995). Improved efficacy and fewer side effects under clozapine therapy after addition of fluvoxamine. Journal of Clinical Psychopharmacology, 15, 141-143.
71. Szymanski, S., Lieberman, J., Picou, D., Masiar, S. and Cooper, T. (1991). A case report of cimetidine-induced clozapine toxicity. Journal of Clinical Psychiatry, 52, 21-22.
72. Tiihonen, J., Vartiainen, H. and Hakola, P. (1994). Carbamazepine-induced changes in plasma levels of neuroleptics. Pharmacopsychiatry, 28, 26-28.
73. Tyson, S., DeVane, C. and Risch, C. (1995). Pharmacokinetic interaction between risperidone and clozapine. American Journal of Psychiatry, 152, 1401-1402.
74. Vainer, J. and Chouinard, G. (1994). Interaction between caffeine and clozapine. Journal of Clinical Psychopharmacology, 14, 284-285.
75. Valevski, A., Modai, I., Lahav, M. and Weizman, A. (1993). Clozapine-lithium combined treatment and agranulocytosis. International Clinical Psychopharmacology, 8, 63-65.
76. Vetter, P. and Proppe, D. (1992). Clozapine-induced coma. Journal of Nervous and Mental Disorders, 180, 58-59.
77. Weigmann, H., Miller, H., Dahmen, N., Wetzel, H. and Hiemke, C. (1993). Interaction of fluvoxamine with the metabolism of clozapine. Pharmacopsychiatry, 26, 209.
78. Wilson, W. (1995). Do anticonvulsants hinder clozapine therapy? Biological Psychiatry, 37, 132-133.
79. Wolkowitz, O. M. (1993). Rational polypharmacy in schizophrenia. Annals of Clinical Psychiatry, 5, 79-90.